genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Cancer
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Cancer
Mapping Single-Cell pH Levels Could Hold Key to Improved Cancer Treatments
Genetics
Engineered Probiotic Provides New Approach for Treating Inflammatory Bowel Disease
News
CRISPR’s Unwanted Edits Unmasked Using Faster Cell Free System
Cancer
$70M from Sidney and Caroline Kimmel to Fund Thomas Jefferson U….
Insights
Bioprocessing
Insect Pupae May Transform Protein Production
Bioprocessing
Optimizing Biotherapeutic Onboarding
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
A-Lists
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Cancer
Mapping Single-Cell pH Levels Could Hold Key to Improved Cancer Treatments
Genetics
Engineered Probiotic Provides New Approach for Treating Inflammatory Bowel Disease
Cancer
$70M from Sidney and Caroline Kimmel to Fund Thomas Jefferson U….
Magazine
All
Supplement
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
December 2019 Vol. 39 No. 12
Taking Cell Lines to the Bank
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Dynamic Microbiome
December 2019 Vol. 39 No. 12
Understanding and Overcoming the Immune Response from Synthetic mRNAs
December 2019 Vol. 39 No. 12
Accelerating AAV to the Clinic with Purification Improvements
December 2019 Vol. 39 No. 12
Evaluation of a Small-Scale Perfusion Mimic for Intensified Processes
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Topics
Cancer
Cancer
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cancer
Epigenomics Grants Predictive Biosciences Rights to Use a Biomarker in a Prostate Cancer Test
Cancer
AstraZeneca’s Anti-PD-L1 mAb Imfinzi Meets Phase III NSCLC Trial Endpoint Early
Cancer
PGxHealth Allies with University of Pittsburgh to Determine Response to Anticancer mAbs
Cancer
Tumors Hold Stiff Upper Lip Before Malignancy
Cancer
BZL Biologics and Atlab Pharma Sign Deal for Radiolabeled Antibody against Prostate Cancer
Cancer
A Windfall for Rock Star Researchers
Cancer
Bispecific, Multispecific Antibodies Grapple with Cancer
Cancer
Pancreatic Cancer Genomic Profiling Hints at More Personalized Therapy
Cancer
Tumor-Suppressor Genes Turned Off by 3′ UTR Shortening
News
Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes
Cancer
Amgen, Xencor to Partner on Cancer Immunotherapy, Inflammation Drugs
Cancer
FDA Clears Novartis Kisqali for Combination Breast Cancer Therapy
Cancer
RNAi Gets High Marks in Brain Cancer Study
Cancer
Wellcome Trust Gives PsiOxus £1.8M to Take Oncolytic Virus into Clinical...
Cancer
Novartis Discontinues a Phase III Study in Gastrointestinal Stromal Tumors
1
2
3
...
362
Page 1 of 362
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Firm is also stopping clinical trials with this PAH medication.[olly-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesDec2010Dec10_2010_10596613_GirlInHospitalBedwithHCP_PfizerPullsThelinfromMarket1841495821-324x160.jpg "Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes")
